← Eichor
Condition: Open Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Open

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Phase 4 · 1 location(s) · Prove pharm · NCT06054880Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Phase 2 · 2 location(s) · Jeremy Veenstra-vanderweele · NCT07091279A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3 · 175 location(s) · Janssen Research & Development, LLC · NCT01804686Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Phase 2 · 1 location(s) · National and Kapodistrian University of Athens · NCT07584083Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy
Phase 1 · 1 location(s) · University Hospital of Split · NCT06595329Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT04437329Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3 · 2 location(s) · Shanghai Yizhong Pharmaceutical Co., Ltd. · NCT06752811The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Ad
Phase 2 · 2 location(s) · Golo · NCT05844644Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07494565Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk R
Phase 2 · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07239245Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775A Food-Effect Study of CX11 in Healthy Participants
Phase 1 · 1 location(s) · Vincentage Pharma Co., Ltd · NCT07349381Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT06176534Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05956639A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Phase 1/Phase 2 · 18 location(s) · Pathos AI, Inc. · NCT06785636DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Phase N/A · 1 location(s) · Barnet Dulaney Perkins Eye Centers · NCT06933836Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Su
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351475Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Phase 2 · 1 location(s) · Hunan Cancer Hospital · NCT06752798Study of AZD0754 in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · 15 location(s) · AstraZeneca · NCT06267729Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 29 location(s) · Novartis Pharmaceuticals · NCT06562192Effects of a 6-months Fiber- and Polyphenol-rich Diet on Brain Inflammatory Processes in Perimenopausal Women Living Wit
NA · 1 location(s) · Max Planck Institute for Human Cognitive and Brain Sciences · NCT07501377A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Phase 2/Phase 3 · 1 location(s) · Xiaojun Chen · NCT05316493A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Phase 3 · 106 location(s) · Verastem, Inc. · NCT06072781a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Phase 2 · 43 location(s) · Vertex Pharmaceuticals Incorporated · NCT07161037Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Phase 1 · 5 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT06880081Arginine Replacement Therapy in COVID-19
Phase 2 · 1 location(s) · Emory University · NCT05855330Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (Pro
NA · 1 location(s) · University Hospitals Cleveland Medical Center · NCT05545930
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.